Evidence map›Paper›PMID 26958097›Full record

ArticleBiomicrofluidics2016

A continuous glucose monitoring device by graphene modified electrochemical sensor in microfluidic system.

Zhihua Pu, Chongwei Zou, Ridong Wang, Xiaochen Lai, Haixia Yu, Kexin Xu, Dachao Li

Abstract read
In one paragraph

Article in Biomicrofluidics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Microfluidic-based systems for the management of diabetes.Drug delivery and translational research · 2024
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhihua PuState Key Laboratory of Precision Measuring Technology and Instruments, Tianjin University , Tianjin 300072, China.
Chongwei ZouState Key Laboratory of Precision Measuring Technology and Instruments, Tianjin University , Tianjin 300072, China.ORCID 0000-0001-7288-5846
Ridong WangState Key Laboratory of Precision Measuring Technology and Instruments, Tianjin University , Tianjin 300072, China.ORCID 0000-0002-5449-1752
Xiaochen LaiState Key Laboratory of Precision Measuring Technology and Instruments, Tianjin University , Tianjin 300072, China.ORCID 0000-0001-8996-1948
Haixia YuTianjin Key Laboratory of Biomedical Detecting Techniques and Instruments, Tianjin University , Tianjin 300072, China.
Kexin XuState Key Laboratory of Precision Measuring Technology and Instruments, Tianjin University , Tianjin 300072, China.
Dachao LiState Key Laboratory of Precision Measuring Technology and Instruments, Tianjin University , Tianjin 300072, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper presents a continuous glucose monitoring microsystem consisting of a three-electrode electrochemical sensor integrated into a microfluidic chip. The microfluidic chip, which was used to transdermally extract and collect subcutaneous interstitial fluid, was fabricated from five polydimethylsiloxane layers using micromolding techniques. The electrochemical sensor was integrated into the chip for continuous detection of glucose. Specifically, a single-layer graphene and gold nanoparticles (AuNPs) were decorated onto the working electrode (WE) of the sensor to construct a composite nanostructured surface and improve the resolution of the glucose measurements. Graphene was transferred onto the WE surface to improve the electroactive nature of the electrode to enable measurements of low levels of glucose. The AuNPs were directly electrodeposited onto the graphene layer to improve the electron transfer rate from the activity center of the enzyme to the electrode to enhance the sensitivity of the sensor. Glucose oxidase (GOx) was immobilized onto the composite nanostructured surface to specifically detect glucose. The factors required for AuNPs deposition and GOx immobilization were also investigated, and the optimized parameters were obtained. The experimental results displayed that the proposed sensor could precisely measure glucose in the linear range from 0 to 162 mg/dl with a detection limit of 1.44 mg/dl (S/N = 3). The proposed sensor exhibited the potential to detect hypoglycemia which is still a major challenge for continuous glucose monitoring in clinics. Unlike implantable glucose sensors, the wearable device enabled external continuous monitoring of glucose without interference from foreign body reaction and bioelectricity.

Identifiers

PMID26958097
PMCPMC4769273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.